成人T细胞白血病/淋巴瘤的全基因组图谱
该研究对150例成人T细胞白血病/淋巴瘤(ATL)进行全基因组测序,揭示其遗传改变全景。发现33%病例存在CIC长异构体功能丧失性改变,13%存在REL的3'端截短,并识别56个复发性驱动基因(含11个新基因)。基于驱动改变谱将ATL分为2个分子亚组,具有不同临床和遗传特征。
要点
- ATL中33%存在CIC长异构体功能丧失性改变,选择性增加CD4+CD25+Foxp3+ T细胞。
- 13%病例有REL的3'端截短,导致转录上调和功能获得性蛋白,也常见于弥漫大B细胞淋巴瘤。
- 基于驱动改变谱将ATL分为2个分子亚组,临床和遗传特征不同。
核心结论
- ATL全基因组图谱揭示CIC长异构体失活和REL截短等关键改变,识别56个驱动基因,支持分子分型。
研究设计与样本
- 对150例ATL病例进行全基因组测序(WGS),分析编码和非编码突变、结构变异及拷贝数改变。
主要发现
- 33%的ATL病例存在CIC长异构体功能丧失性改变,短异构体未受影响。
- 13%的ATL病例存在REL的3'端截短,导致转录上调和功能获得性蛋白。
- REL截短在弥漫大B细胞淋巴瘤中也常见,尤其是生发中心B细胞样亚型(12%)。
- 非编码基因组中识别出驱动基因调控元件(尤其剪接位点)的复发性突变。
- 发现56个复发性改变驱动基因,包括11个新基因,并将ATL分为2个分子亚组。
临床怎么用
- 全基因组测序揭示的驱动改变和分子分型有助于改进ATL的诊断和治疗策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Adult T-cell leukemia/lymphoma (ATL) is an aggressive neoplasm immunophenotypically resembling regulatory T cells, associated with human T-cell leukemia virus type-1. Here, we performed whole-genome sequencing (WGS) of 150 ATL cases to reveal the overarching landscape of genetic alterations in ATL. We discovered frequent (33%) loss-of-function alterations preferentially targeting the CIC long isoform, which were overlooked by previous exome-centric studies of various cancer types. Long but not short isoform-specific inactivation of Cic selectively increased CD4+CD25+Foxp3+ T cells in vivo. We also found recurrent (13%) 3'-truncations of REL, which induce transcriptional upregulation and generate gain-of-function proteins. More importantly, REL truncations are also common in diffuse large B-cell lymphoma, especially in germinal center B-cell-like subtype (12%). In the non-coding genome, we identified recurrent mutations in regulatory elements, particularly splice sites, of several driver genes. In addition, we characterized the different mutational processes operative in clustered hypermutation sites within and outside immunoglobulin/T-cell receptor genes and identified the mutational enrichment at the binding sites of host and viral transcription factors, suggesting their activities in ATL. By combining the analyses for coding and noncoding mutations, structural variations, and copy number alterations, we discovered 56 recurrently altered driver genes, including 11 novel ones. Finally, ATL cases were classified into 2 molecular groups with distinct clinical and genetic characteristics based on the driver alteration profile. Our findings not only help to improve diagnostic and therapeutic strategies in ATL, but also provide insights into T-cell biology and have implications for genome-wide cancer driver discovery.
引用
- Kogure Y, Kameda T, Koya J, et al. Whole-genome landscape of adult T-cell leukemia/lymphoma. Blood. 2022. PMID: 34695199. doi:10.1182/blood.2021013568
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。